Cargando…
1385. Mechanism-Based, In Vitro Inhibition of Mycobacterium abscessus: Assessing β-Lactam Therapy
BACKGROUND: M. abscessus (Mab) is an emerging pathogen, a highly drug-resistant rapidly-growing nontuberculous mycobacteria. Mab L, D transpeptidases (Ldt(Mab 1–5)), D,D carboxypeptidase and Bla(Mab) β-lactamase are important targets. Herein, we tested the susceptibility of ceftaroline (TAR) and imi...
Autores principales: | Dousa, Khalid M, Kurz, Sebastian G, Bethel, Christopher R, Barnes, Melissa D, Taracilla, Magdalena A, Selvaraju, Suresh, Jacobs, Michael R, Kreiswirth, Barry, Kasperbauer, Shannon H, Daley, Charles L, Bonomo, Robert A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809419/ http://dx.doi.org/10.1093/ofid/ofz360.1249 |
Ejemplares similares
-
786. Ceftaroline and Avibactam? Is This a Potential Combination for Mycobacterium abscessus Infection?
por: Dousa, Khalid M, et al.
Publicado: (2018) -
Eradicating Pulmonary Mycobacterium abscessus: The Promise of Dual β-Lactam Therapy
por: Alahmdi, Bayan, et al.
Publicado: (2023) -
1642. A Novel β-lactamase Inhibitor (Durlobactam, DUR) and β-Lactams Enhance Susceptibility Against Multidrug-Resistant (MDR) Mycobacterium abscessus (Mab)
por: Dousa, Khalid M, et al.
Publicado: (2020) -
2806. The Mechanism of β-Lactam Antibiotic Action: Structural Analysis of Mycobacterium abscessus l,d-Transpeptidases, d,d-Carboxypeptidase and penicillin-binding-proteins binding by imipenem, ceftaroline, and amoxicillin
por: Shin, Eunjeong, et al.
Publicado: (2023) -
Inhibiting Mycobacterium abscessus Cell Wall Synthesis: Using a Novel Diazabicyclooctane β-Lactamase Inhibitor To Augment β-Lactam Action
por: Dousa, Khalid M., et al.
Publicado: (2022)